Takeda will cut 2,800 jobs to integrate Nycomed
Takeda has announced it will cut 2,800 jobs by 2015 as part of its integration of Nycomed.
Takeda has announced it will cut 2,800 jobs by 2015 as part of its integration of Nycomed.
Quintiles has invested £3m ($4.6m) in a new UK-based biomarker R&D company in a continuation of its efforts to build in the field of personalised medicines.
Training and consultancy firm NSF Health Sciences (NSF-DBA) has acquired Pink Associates in a bid to broaden its service offering.
A new study has found a way to use air as a barrier for controlled drug release.
VivoPharm says its new agreement with primary patient-derived tumour creators EPO-GmbH will bring drug candidate selection to a “new level” for US drug researchers.
CMO Paragon Bioservices has won a $15m DoD contract to develop a large-scale mammalian process for a trivalent filovirus vaccine.
Sigma-Aldrich is prioritising HPAPIs as it seeks to grow its custom pharma business in the face of low-cost competition.
Enzymicals and Herbrand PharmaChemicals have partnered to incorporate biocatalytic processes into fine chemical manufacturing.
Clinical research associates (CRAs) spend less than half of their time conducting ‘on site’ monitoring with training, travel and admin taking up the majority of their time according to new research